Education

NEET-PG 2024 exam rescheduled to July 7

The National Eligibility-cum-Entrance Test-Postgraduate examination has been rescheduled to July 7 this year, the National Board of Examinations in Medical Sciences said on Tuesday. The cut-off date for the purpose of eligibility for the exam this year is August 15.

The exam was earlier scheduled to be held on March 3. “In supersession of NBEMS notice dated 09.11.2023 and pursuant to the receipt of NMC letter dated January 3, 2024, the conduct of NEET-PG 2024 examination, which was earlier notified to be tentatively held on March 3, 2024, stands rescheduled,” the NBEMS said in a notice. “The NEET-PG 2024 shall now be conducted on July 7, 2024,” it said.

Welcoming the decision, Dr Arival Mathur, President, Federation of Resident Doctors of Association, said, “The extended gap between counseling and the exam, being addressed through the rescheduling of exam, is a positive step that recognizes the ongoing challenges posed by the lingering effects of the COVID-19 pandemic. We hope that the adjustment will contribute to a more streamlined academic session, considering the persisting disruptions caused by the pandemic”.

The NEET-PG is an eligibility-cum-ranking examination prescribed as the single entrance examination for admission to various MD/MS and PG diploma courses under the National Medical Commission Act, 2019.

Medlarge

Recent Posts

AIIMS Doctor perform congenital lung malformation rare surgery on 4-month child

Doctors at AIIMS Delhi have successfully performed a rare and technically demanding lung-preserving surgery on…

1 week ago

22-year-old woman undergoes for decade long facial tumour through Scarless Surgery

Sharda Hospital successfully performed a rare scarless surgery to remove a massive benign facial tumor…

3 weeks ago

29-year-old woman undergoes breast reconstruction for childhood burn deformity

A 29-year-old woman with a severe post-burn deformity of the left chest and breast, resulting…

3 weeks ago

Zydus signs MoU with Apollo Hospitals for multi-cancer early detection test

Zydus Lifesciences with Guardant Health, having an agreement to make the Shield™ Multi-Cancer Detection (MCD)…

3 weeks ago

Why India needs uniform strategy for equitable access to Cancer treatment, experts explain

In the backdrop of observation that India may emerge as the Cancer Capital of the…

3 weeks ago

Centre bans sale of Cough syrups without valid prescription

The Centre has amended the Drugs rule, omitting the word “Syrup” from Schedule K, the…

1 month ago